Skip to content

Author

Akihide Yoshimi

We have 2 of 34 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Multiplex Immunofluorescence-defined CXCL13-associated TLS-like Niches Predict Outcome in Bladder Cancer.

PURPOSE Spatially organized tertiary lymphoid structure (TLS)-like niches may provide prognostic and therapeutic information beyond individual immune mediators such as CXCL13 in bladder cancer (BC). We evaluated the clinical and translational significance of multiplex immunofluorescence-defined TLS-like structures (mTL...

R. Maenosono, Kazuki Nishimura, T. Tsujino et al. · 0 citations
Open access Sep 2026

Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives.

Progress will require more selective splicing-directed modalities, pharmacodynamic biomarkers that measure splicing perturbation in the relevant tumor or blood compartment, longitudinal mapping of genetic and tumor cell-state plasticity-driven resistance, and biomarker-defined combination trials to support expansion fr...

Xinbate Jingele, Qinxinru Sun, Xiao-Yang Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.